BBC

BioShares Biotechnology Clinical Trials ETF

Down$27.51
$-0.07
(-0.25%)
As of 11:48:20 AM EDT | 11/18/19  |  Market Open

BBC Trading Data

Open

$27.52

Low Price

$27.51

High Price

$27.71

Previous Last Price

$27.59

Bid Size

$27.43 X 300

Ask Size

$27.48 X 100

BBC Portfolio Data

AUM

$24,669,000

Shares

900

PE Ratio

0

Price / Book Ratio

3.47

Expense Ratio

0.79

Net Asset Value

$27.41

Volume

Volume

950

Avg. Volume (YDT)

5,582

Dollar Volume

$19,385

Weekly Avg. Volume

1,430

Monthly Avg. Volume

2,717

Quarterly Avg. Volume

3,982

BBC Fund Description

The BioShares Biotechnology Clinical Trials Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drugs.

BBC Chart

BBC Summary

Fund Family

BioShares

Tracks This Index

BioShares Biotechnology Clinical Trials ETF

Inception Date

2014-12-17

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

BBC Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBC Holdings

Top 10 Holdings

Virtus LifeSci Biotech Clinical Trials ETF (BBC)
0%
%
%
%
%
%
%
%
%
%

Total BBC Holdings

Total Holdings: 1

Virtus LifeSci Biotech Clinical Trials ETF (BBC)
0%

BBC Technicals

Alpha

-7.34

Beta

1.73

Leverage

Long

Standard Deviation

1.64

BBC Dividends

Dividend Date

2017-12-20

Latest Dividend

0.297

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

BBC Performance

YTD Return

19.3%

1 Year Return

2%

3 Year Return

27.54%

5 Year Return

0%

10 Year Return

-0.55%

BBC Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.